Dr Alexia Pena Vargas
Dr Alexia Peña is a Paediatrician originally trained in Colombia, South America. She migrated to Australia in 2000 to complete her training in Paediatric Endocrinology (FRACP). She completed her PhD in 2008 examining early markers of cardiovascular disease and strategies to improve vascular health in children with type 1 diabetes and obesity. Her research in childhood vascular health has been published in high impact factor journals and has been presented nationally and internationally.
Dr Peña has also a strong research interest in Adolescent Polycystic Ovary Syndrome (PCOS). She is an investigator of the PCOS NHMRC Centre for Research Excellence and an active participant in the international initiative to build PCOS awareness that will generate an international Evidence-Based guideline for the assessment and management of PCOS currently under public consultation. This followed an initial national guidelines approved by the NHMRC in 2011. Her expertise has been recognised at an international level with her appointment as a member of the international consensus group on Adolescent Polycystic Ovary Syndrome (PCOS).
Dr Peña is a Senior Lecturer at The University of Adelaide and a Staff Specialist at the Women’s and Children’s Hospital.
✓ Eligible to supervise Masters and PhD — email supervisor to discuss availability.
Dr Peña has strong research interest into early markers of cardiovascular disease in children with type 1 diabetes or obesity, and strategies to prevent cardiovascular disease from childhood.
She has also a strong research interest in management of childhood and adolescent obesity; and its comorbidities including Polycystic Ovary Syndrome. She is part of the Centre for Research Excellence in the evaluation, management and health care needs of Polycystic Ovary Syndrome and related health implications.
|2011||Senior Lecturer||University of Adelaide|
|2009||Paediatric Endocrinologist||Children’s, Youth and Women’s Health Service|
|2008 - 2011||Clinical Lecturer||University of Adelaide|
|2016||Nomination||Award nomination for student teaching||—||—||—|
|2014||Award||Kaichi Kida APPES Presentation Award||—||—||—|
|2013||Invitation||Australian representatives to attend the European Society of Paediatric Endocrinology Science School in Haifa Israel||—||—||—|
|French||Can read and understand spoken|
|Spanish; Castilian||Can read, write, speak, understand spoken and peer review|
|2018||Pena, A., Hoeger, K., Oberfield, S., Witchel, S., Vogiatzi, M., Misso, M., & Teede, H. (2018). Diagnosis and Treatment of Adolescent Polycystic Ovary Syndrome (PCOS) According to the 2018 International Evidence-Based Guideline for the Assessment and Management of PCOS. In AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY Vol. 58 (pp. 4-5). WILEY.|
|2018||Pena, A., Witchel, S., Hoeger, K., Oberfield, S., Vogiatzi, M., Misso, M., & Teede, H. (2018). Pharmacological Treatment of Adolescent Polycystic Ovary Syndrome (PCOS) According to the 2018 International Evidence-Based Guideline for the Assessment and Management of PCOS. In HORMONE RESEARCH IN PAEDIATRICS Vol. 90 (pp. 99-100). KARGER.|
|2018||Pena, A., Hoeger, K., Oberfield, S., Wiitchel, S., Vogiatzi, M., Misso, M., & Teede, H. (2018). Diagnosis of Adolescent Polycystic Ovary Syndrome (PCOS) According to the 2018 International Evidence-Based Guideline for the Assessment and Management of PCOS. In HORMONE RESEARCH IN PAEDIATRICS Vol. 90 (pp. 551). KARGER.|
Grants and Funding
|2015||Do vascular benefits of metformin persist during puberty in type 1 diabetes? Adelaide Metformin RCT follow up study.||Peña AS Chief investigator.||WCH Project grant||$74,734|
|20156||Measurement of metformin levels in the analysis of Adelaide Metformin randomized controlled trial”.||Peña AS Chief investigator||Ms McLeod Departmental Research Grant 2015||$10000|
|2015||APP1078444 Centre for Research Excellence in the evaluation, management and health care needs of Polycystic Ovary Syndrome and related health implications||Peña AS Associate Investigator||NHMRC 2015||$2,489,052|
|2013||APP1067807 Cystic Fibrosis ‐ Insulin Deficiency, Early Action (CF‐IDEA)||Peña AS Associate investigator||NHMRC 2013||$180,758|
|2013||Is hyperandrogenism a risk factor for vascular health in adolescent girls with type 1 diabetes?||Peña AS Chief investigator||Ms McLeod Departmental Research Grant 2013||$10000|
|2012||Does Metformin improve vascular structure in overweight youth with type 1 diabetes?||Peña AS Associate Investigator||Diabetes Australia Research Grant 2012||$58840|
|2011||Does Metformin improve vascular function in overweight youth with type 1 diabetes?||Peña AS – Associate Investigator||WCH Project grant 2011||$50000|
|2010||Does Metformin improve vascular function in overweight youth with type 1 diabetes?||Peña AS – Chief Investigator||APEC Pfizer Grants 2010||$50000|
|2009||What is the minimum dose of folic acid that improves vascular health in children with type 1 diabetes?||Peña AS – Chief investigator||WCH foundation Research Project grant 2009||$50000|
|2006||Peri pubertal changes in vascular function in children with type 1 diabetes and obesity.||Peña AS – Chief investigator||The APEG Novo Nordisk Research Grant 2006||$25000|
Medical Students: Small group medical tutorials (4-5 students per tutorial) per term.
Write questions for OSCE medical exams and barrier exam.
Examiner of OSCE and barrier exam.
Examiner of observer clinical assessment of 5th year medical students
|Date||Role||Research Topic||Program||Degree Type||Student Load||Student Name|
|2010 - 2014||Co-Supervisor||Monitoring of vascular health in children at risk for atherosclerosis||Doctor of Philosophy||Doctorate||Full Time||Ms Jennifer Jean Harrington|
|2015 - ongoing||Member||Organizing committee International Society for Pediatric and Adolescent Diabetes/APEG||—||—|
|2013 - ongoing||Secretary||APEG Australian Paediatric Endocrine Group||—||—|
|2013 - ongoing||Member||Organising committee 23rd Annual Scientific Meeting ANZOS||—||—|
|2012 - ongoing||Member||Organising committee 22nd Annual Scientific Meeting ANZOS||—||New Zealand|
|2011 - ongoing||Representative||DSD Subcommittee||—||—|
|2011 - ongoing||Chair||Organising committee 21st Annual Scientific Meeting ANZOS||—||—|
|2010 - ongoing||Member||Local organizing committee Annual Scientific Meeting APEG||—||—|
|2009 - 2012||Member||Diabetes Database Subcommittee APEG||—||—|
|2009 - ongoing||Council||APEG Australian Paediatric Endocrine Group||—||—|
|2009 - 2013||Council||ASSO/ANZOS The Australian and New Zealand Obesity Society||—||—|
|2006 - 2012||Member||Drug Therapeutic Committee Clinical Trials Review Working Party||Children, Youth and Women’s Health Service||Australia|
|2016 - ongoing||Women’s and Children’s Hospital||—||—||—|
|2013 - ongoing||Women’s & Children’s Health Network||—||—||—|
|Date||Role||Editorial Board Name||Institution||Country|
|2016 - ongoing||Member||Journal of Paediatric Child Health||—||—|
|2013 - ongoing||Member||Colombian National Academy of Medicine Journal||—||—|